Cash discounts, while still rare, are up over 60% from 2015. Here's how much you can save
https://www.cnbc.com/2024/05/26/when-paying-with-cash-can-be-better-than-credit-card.html
May 26, 2024 - More merchants are giving discounts to consumers who pay with cash, or putting surcharges on credit card purchases.
0
Here's What Happens When You Don't Sign Up for Medicare On Time
https://www.fool.com/retirement/2024/05/25/heres-what-happens-when-you-dont-sign-up-for-medic/?source=iedfolrf0000001
May 25, 2024 - Delaying your Medicare enrollment too long could have serious consequences.
0
Novo Nordisk once weekly insulin fails to get thumbs up from majority of FDA advisors
https://seekingalpha.com/news/4110352-novo-nordisk-once-weekly-insulin-fails-get-thumbs-up-majority-fda-advisors?source=feed_sector_healthcare
May 24, 2024 - FDA advisory panel expresses concerns about the risks of Novo Nordisk's once-weekly insulin icodec outweighing the benefits. Read more here.
0
Ross Stores (ROST) Q1 Earnings & Sales Beat Estimates, Up Y/Y
https://www.zacks.com/stock/news/2278947/ross-stores-rost-q1-earnings-sales-beat-estimates-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2278947
May 24, 2024 - Ross Stores (ROST) reports solid first-quarter fiscal 2024 results on gains from customers' favorable response to quality and other strategies.
0
Aflac (AFL), Nayya Team Up to Ease Clients' Claim Experience
https://www.zacks.com/stock/news/2278928/aflac-afl-nayya-team-up-to-ease-clients-claim-experience?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2278928
May 24, 2024 - Aflac (AFL) joins forces with Nayya, whose medical claims integration solution will be put to use to ease claims experience and result in the higher utilization of the insurer's supplemental health benefits.
0
Apellis Pharma up on phase 2 data for kidney disease treatment pegcetacoplan
https://seekingalpha.com/news/4110307-apellis-pharma-up-phase-2-data-kidney-disease-treatment-pegcetacoplan?source=feed_sector_healthcare
May 24, 2024 - Pegcetacoplan, an investigational drug from Apelli, shows promising results in reducing disease activity in patients with glomerulopathy. Read more here.
0
Viasat (VSAT), Azercosmos Team Up to Boost Satellite Communication
https://www.zacks.com/stock/news/2278893/viasat-vsat-azercosmos-team-up-to-boost-satellite-communication?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2278893
May 24, 2024 - Azercosmos opts to leverage Viasat's (VSAT) satellite services portfolio to deliver robust connectivity for various industries, including agriculture, mining, utilities, energy and more.
0
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
https://www.zacks.com/stock/news/2278892/verastem-vstm-up-on-upbeat-early-pancreatic-cancer-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2278892
May 24, 2024 - Verastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line patients treated with novel combo therapy in the initial cohort of its phase I/II pancreatic cancer study.
0
Ericsson (ERIC), Dell Team Up to Boost Network Transformation
https://www.zacks.com/stock/news/2278891/ericsson-eric-dell-team-up-to-boost-network-transformation?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2278891
May 24, 2024 - Ericsson (ERIC) partners with Dell to integrate their combined expertise to accelerate cloud network modernization and unlock growth opportunities for service providers.
0
ProPetro Holding (PUMP) Is Up 4.76% in One Week: What You Should Know
https://www.zacks.com/stock/news/2278871/propetro-holding-pump-is-up-4-76-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2278871
May 24, 2024 - Does ProPetro Holding (PUMP) have what it takes to be a top stock pick for momentum investors? Let's find out.
0